<p>Naive C57BL/6 mice (two mice per group) were immunized with DEX particle formulations as indicated. On days 7 (upper panel) and 14 (lower panel), mice were bled and derived sera were used for detection of OVA-specific IgG1 and IgG2a antibody titers. Data represent mean±SEM of two sera per group.</p
<p>Mice were OVA-sensitized as described in <a href="http://www.plosone.org/article/info:doi/10.1371...
<p>WT and CD14<sup>−/−</sup> mice were immunized with LPS plus OVA or LPS-OVA-liposomes (10 µg each ...
<p>(A-D and F-H) <i>Cd155<sup>−/−</sup></i> mice (n = 12) and WT littermate (n = 12) were immunize...
<p>(A) Mice (C57BL/6) received CFSE-labeled OVA-specific OT-II T cells (10<sup>7</sup>/mouse) <i>i.v...
<p>WT mice were immunized with LPS+OVA, OVA-liposomes, or LPS-OVA-liposomes (10 µg each per mouse, i...
<p>C57BL/6 mice received CFSE-labeled, OVA-specific OT-I T cells (10<sup>7</sup>) <i>i.v.</i> Two da...
<p>The DDA:TDB+OVA formulations indicated along the X-axis were given to C57/BL6 mice as three homol...
<p>Fecal pellets were collected each week from individual mice and fecal extracts were assayed by EL...
<p>(A) Aliquots of unstimulated day 6 BM-DCs (10<sup>6</sup> cells; C57BL/6) were left untreated (−)...
<p>Mice were administered PBS (control), soluble Ova, or 20 nm NP-Ova p.o. at day 0, 3, 6 and 8, the...
<p>C3H/HeN and C3H/Hen mice were intranasally immunized with OVA plus 500 µg of PMB 3 times at weekl...
<p>Mice were immunized vaginally with 20 nm NP-Ova or PBS (control), then s.c. boosted with 300 µg O...
<p>Mice were intranasally immunized with ovalbumin (OVA) plus 0, 2.5, 5, 10, 25, 50, 100, 250, or 50...
<p>(a,b) Supernatants of 293E cells transfected with the indicated plasmids were tested for secreted...
<p>Serum samples of WT and <i>mev/+</i> mice were collected within 2 hrs after challenge and OVA all...
<p>Mice were OVA-sensitized as described in <a href="http://www.plosone.org/article/info:doi/10.1371...
<p>WT and CD14<sup>−/−</sup> mice were immunized with LPS plus OVA or LPS-OVA-liposomes (10 µg each ...
<p>(A-D and F-H) <i>Cd155<sup>−/−</sup></i> mice (n = 12) and WT littermate (n = 12) were immunize...
<p>(A) Mice (C57BL/6) received CFSE-labeled OVA-specific OT-II T cells (10<sup>7</sup>/mouse) <i>i.v...
<p>WT mice were immunized with LPS+OVA, OVA-liposomes, or LPS-OVA-liposomes (10 µg each per mouse, i...
<p>C57BL/6 mice received CFSE-labeled, OVA-specific OT-I T cells (10<sup>7</sup>) <i>i.v.</i> Two da...
<p>The DDA:TDB+OVA formulations indicated along the X-axis were given to C57/BL6 mice as three homol...
<p>Fecal pellets were collected each week from individual mice and fecal extracts were assayed by EL...
<p>(A) Aliquots of unstimulated day 6 BM-DCs (10<sup>6</sup> cells; C57BL/6) were left untreated (−)...
<p>Mice were administered PBS (control), soluble Ova, or 20 nm NP-Ova p.o. at day 0, 3, 6 and 8, the...
<p>C3H/HeN and C3H/Hen mice were intranasally immunized with OVA plus 500 µg of PMB 3 times at weekl...
<p>Mice were immunized vaginally with 20 nm NP-Ova or PBS (control), then s.c. boosted with 300 µg O...
<p>Mice were intranasally immunized with ovalbumin (OVA) plus 0, 2.5, 5, 10, 25, 50, 100, 250, or 50...
<p>(a,b) Supernatants of 293E cells transfected with the indicated plasmids were tested for secreted...
<p>Serum samples of WT and <i>mev/+</i> mice were collected within 2 hrs after challenge and OVA all...
<p>Mice were OVA-sensitized as described in <a href="http://www.plosone.org/article/info:doi/10.1371...
<p>WT and CD14<sup>−/−</sup> mice were immunized with LPS plus OVA or LPS-OVA-liposomes (10 µg each ...
<p>(A-D and F-H) <i>Cd155<sup>−/−</sup></i> mice (n = 12) and WT littermate (n = 12) were immunize...